NCT06987994Completed
The Effect of Virtual Reality on Fatigue and Functional Capacity in Patients With MS
The Effect of Virtual Reality on Fatigue and Functional Capacity in Patients With Multiple Sclerosis
Source: ClinicalTrials.gov · Last updated 23 May 2025
Brief summary (registry, in English)
This clinical trial aims to evaluate the effectiveness of virtual reality (VR) as a complementary intervention to traditional physical therapy for individuals diagnosed with Multiple Sclerosis (MS). MS is a chronic neurological condition that affects motor and cognitive functions, with fatigue being one of the most common and disabling symptoms. This study will assess whether the use of VR-based applications, in addition to standard physiotherapy, can reduce fatigue and improve functional capacity in individuals with MS. Participants will be randomly assigned to two groups: one group will receive conventional physiotherapy only, while the other will receive VR-based therapy alongside physiotherapy. The intervention period will last four weeks, and both groups will be evaluated using standardized outcome measures before and after the intervention. These include the Fatigue Severity Scale (FSS), the Timed Up and Go (TUG) test, and the 6-Minute Walk Test (6MWT). The study is designed to address a gap in current literature, as no prior research has specifically examined the impact of virtual reality on fatigue and functional performance in MS patients. The findings may provide valuable insights into innovative rehabilitation strategies that enhance patient outcomes and improve quality of life.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 30 (actual)
- First submitted
- 16 May 2025
- Start date
- Dec 2024
- Primary completion date
- Feb 2025
- Lead sponsor
- Istinye University
- Diseases
- Multiple sclerosis
- NCT number
- NCT06987994
What you commit to
- Study type: Interventional
- Participants enrolled: 30
- From Dec 2024 to the primary completion date, Feb 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- 1\. cognitive disorders hampering the execution of the exercises/assessment, 2. Ability to maintain monopodalic-standing position for 10 s 3. cardiovascular disorders 4. orthopedic disorders that could negatively affect balance 5. uncorrected visual or auditory impairments 6. pregnancy
Who the study is looking for
- individuals diagnosed as MS by a physician
- Expanded Disability Status Scale (EDSS): 2.0-6.5
- Patient able to walk with or without the use of unilateral support (e.g., a cane)
- Patient had not experienced a severe exacerbation of symptoms requiring medical intervention in the previous month
- subjects had to have the cognitive capacity to assure the requisite cognitive ability
- spasticity up to 2 on Ashworth scale.
Age in the registry: 20 years to 85 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Istinye University Faculty of Health Sciences, Physiotherapy and Rehabilitation Department Coordinator of this site? Confirm its status | Istanbul | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.